FTM
BECOME A MEMBER
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: LiveWell Canada

  • Home
  •  | 
  • Tag Archives: "LiveWell Canada"

LiveWell Canada Inc. Signs a Major CBD Supply Agreement in Brazil

LiveWell Canada Inc. Signs a Major CBD Supply Agreement in Brazil
There is a growing body of evidence as to CBD's positive health effects including: pain relief, combatting mood disorders, lowering inflammation, fighting cancer, etc. The U.S. FDA just approved the first CBD-based drug, called Epidiolex(®), for treatment-resistant epilepsy syndromes. The scientific evidence keeps building every day. CBD is undergoing pre-clinical testing and clinical trials for many diseases. As research on CBD continues, other mechanisms of action are being discovered. Thus, the number of potentially treatable diseases continues to increase. Clinical trials are ongoing for other conditions including multiple sclerosis, neuropathic pain, schizophrenia, bipolar mania, anxiety, insomnia, and Huntington's disease.
Read more

LiveWell to Open TSX Venture Exchange on August 21, 2018

LiveWell to Open TSX Venture Exchange on August 21, 2018
LiveWell to Open TSX Venture Exchange on August 21, 2018 /DO NOT DISTRIBUTE TO U.S. NEWS WIRE AGENCIES OR PUBLISH, DISTRIBUTE OR DISSEMINATE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO THE UNITED STATES (USA)/ TORONTO, Aug 20, 2018 /CNW Telbec/ - LIVEWELL CANADA Inc. ("LiveWell" or the "Company") (TSX-V: LVWL), is pleased to announce the opening of the TSX Venture…
Read more

LiveWell Canada Secures Large Supply of Industrial Hemp Biomass

LiveWell Canada Secures Large Supply of Industrial Hemp Biomass
GATINEAU, QC, Aug. 13, 2018 /CNW Telbec/ - LIVEWELL CANADA INC. (TSXV: LVWL) ("LiveWell Canada" or the "Company") is pleased to announce that it has secured 1,000 acres of Canadian industrial hemp biomass for the purpose of extracting and producing cannabinoid (including "CBD") based products for distribution in Canada. Using current extraction technology licensed to LiveWell, the Company anticipates extracting approximately 25,000 kg of CBD for sale under the Access to Cannabis for Medical Purpose Regulations ("ACMPR"). It is expected to be harvested in mid-August 2018 and brought to market in 2019. Based on observable broker quotations, the current wholesale value for each kilogram of CBD isolate is approximately US$6,500. Additionally, as part of this transaction, LiveWell secured an option to buy an additional 1,000 acres of Canadian industrial hemp biomass at the same price no later than September 30, 2018. The total purchase consideration for this transaction, including the option, was US$10 million.1
Read more